Genetic Classification of Gliomas: Refining Histopathology

作者: Michael B. Foote , Nickolas Papadopoulos , Luis A. Diaz

DOI: 10.1016/J.CCELL.2015.06.014

关键词: ATRXGliomaIDH1BiologyBioinformaticsHistopathology

摘要: Newly published studies validate prior reports that specific combinations of genetic alternations in IDH1/2, ATRX, TERT, TP53, and co-deletion 1p/19q have the ability to reclassify gliomas into rational subsets, defining a glioma's biological clinical behavior more accurately than stratifications based solely on histopathology.

参考文章(10)
Tarik Tihan, Mitchell S. Berger, Susan M. Chang, Michael D. Prados, Joseph Wiemels, John K. Wiencke, Margaret R. Wrensch, Robert B. Jenkins, Jeanette E. Eckel-Passow, Daniel H. Lachance, Annette M. Molinaro, Kyle M. Walsh, Paul A. Decker, Hugues Sicotte, Melike Pekmezci, Terri Rice, Matt L. Kosel, Ivan V. Smirnov, Gobinda Sarkar, Alissa A. Caron, Thomas M. Kollmeyer, Corinne E. Praska, Anisha R. Chada, Chandralekha Halder, Helen M. Hansen, Lucie S. McCoy, Paige M. Bracci, Roxanne Marshall, Shichun Zheng, Gerald F. Reis, Alexander R. Pico, Brian P. O’Neill, Jan C. Buckner, Caterina Giannini, Jason T. Huse, Arie Perry, Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors The New England Journal of Medicine. ,vol. 372, pp. 2499- 2508 ,(2015) , 10.1056/NEJMOA1407279
Cancer Genome Atlas Research Network, None, Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. The New England Journal of Medicine. ,vol. 372, pp. 2481- 2498 ,(2015) , 10.1056/NEJMOA1402121
Yuchen Jiao, Patrick J. Killela, Zachary J. Reitman, B. Ahmed Rasheed, Christopher M. Heaphy, Roeland F. de Wilde, Fausto J. Rodriguez, Sergio Rosemberg, Sueli Mieko Oba-Shinjo, Suely Kazue Nagahashi Marie, Chetan Bettegowda, Nishant Agrawal, Eric Lipp, Christopher J. Pirozzi, Giselle Y. Lopez, Yiping He, Henry S. Friedman, Allan H. Friedman, Gregory J. Riggins, Matthias Holdhoff, Peter Burger, Roger E. McLendon, Darell D. Bigner, Bert Vogelstein, Alan K. Meeker, Kenneth W. Kinzler, Nickolas Papadopoulos, Luis A. Diaz, Hai Yan, Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas. Oncotarget. ,vol. 3, pp. 709- 722 ,(2012) , 10.18632/ONCOTARGET.588
Matthias Holdhoff, Xiaobu Ye, Jaishri O Blakeley, Lindsay Blair, Peter C Burger, Stuart A Grossman, Luis A Diaz, None, Use of personalized molecular biomarkers in the clinical care of adults with glioblastomas Journal of Neuro-oncology. ,vol. 110, pp. 279- 285 ,(2012) , 10.1007/S11060-012-0968-3
C. Bettegowda, N. Agrawal, Y. Jiao, M. Sausen, L. D. Wood, R. H. Hruban, F. J. Rodriguez, D. P. Cahill, R. McLendon, G. Riggins, V. E. Velculescu, S. M. Oba-Shinjo, S. K. N. Marie, B. Vogelstein, D. Bigner, H. Yan, N. Papadopoulos, K. W. Kinzler, Mutations in CIC and FUBP1 Contribute to Human Oligodendroglioma Science. ,vol. 333, pp. 1453- 1455 ,(2011) , 10.1126/SCIENCE.1210557
Adriana Olar, Erik P. Sulman, Molecular Markers in Low-Grade Glioma-Toward Tumor Reclassification. Seminars in Radiation Oncology. ,vol. 25, pp. 155- 163 ,(2015) , 10.1016/J.SEMRADONC.2015.02.006
D. W. Parsons, S. Jones, X. Zhang, J. C.-H. Lin, R. J. Leary, P. Angenendt, P. Mankoo, H. Carter, I-M. Siu, G. L. Gallia, A. Olivi, R. McLendon, B. A. Rasheed, S. Keir, T. Nikolskaya, Y. Nikolsky, D. A. Busam, H. Tekleab, L. A. Diaz, J. Hartigan, D. R. Smith, R. L. Strausberg, S. K. N. Marie, S. M. O. Shinjo, H. Yan, G. J. Riggins, D. D. Bigner, R. Karchin, N. Papadopoulos, G. Parmigiani, B. Vogelstein, V. E. Velculescu, K. W. Kinzler, An Integrated Genomic Analysis of Human Glioblastoma Multiforme Science. ,vol. 321, pp. 1807- 1812 ,(2008) , 10.1126/SCIENCE.1164382
Janet M. Bruner, Lila Inouye, Gregory N. Fuller, Lauren A. Langford, Diagnostic discrepancies and their clinical impact in a neuropathology referral practice. Cancer. ,vol. 79, pp. 796- 803 ,(1997) , 10.1002/(SICI)1097-0142(19970215)79:4<796::AID-CNCR17>3.0.CO;2-V
Robert B. Jenkins, Hilary Blair, Karla V. Ballman, Caterina Giannini, Robert M. Arusell, Mark Law, Heather Flynn, Sandra Passe, Sara Felten, Paul D. Brown, Edward G. Shaw, Jan C. Buckner, A t(1;19)(q10;p10) Mediates the Combined Deletions of 1p and 19q and Predicts a Better Prognosis of Patients with Oligodendroglioma Cancer Research. ,vol. 66, pp. 9852- 9861 ,(2006) , 10.1158/0008-5472.CAN-06-1796
P. J. Killela, Z. J. Reitman, Y. Jiao, C. Bettegowda, N. Agrawal, L. A. Diaz, A. H. Friedman, H. Friedman, G. L. Gallia, B. C. Giovanella, A. P. Grollman, T.-C. He, Y. He, R. H. Hruban, G. I. Jallo, N. Mandahl, A. K. Meeker, F. Mertens, G. J. Netto, B. A. Rasheed, G. J. Riggins, T. A. Rosenquist, M. Schiffman, I.-M. Shih, D. Theodorescu, M. S. Torbenson, V. E. Velculescu, T.-L. Wang, N. Wentzensen, L. D. Wood, M. Zhang, R. E. McLendon, D. D. Bigner, K. W. Kinzler, B. Vogelstein, N. Papadopoulos, H. Yan, TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal Proceedings of the National Academy of Sciences of the United States of America. ,vol. 110, pp. 6021- 6026 ,(2013) , 10.1073/PNAS.1303607110